Literature DB >> 2410274

Monoclonal antibodies to Torpedo acetylcholine receptor. Characterisation of antigenic determinants within the cholinergic binding site.

P Whiting, A Vincent, J Newsom-Davis.   

Abstract

Thirteen monoclonal antibodies (mAb) to the acetylcholine receptor (AChR) from Torpedo marmorata showed high avidity for the receptor but none exhibited binding to muscle AChR solubilised from seven other animal species. Five mAb and Fab monomer fragments prepared from two of them, inhibited alpha-bungarotoxin (alpha BuTx) binding to receptor by a maximum of 50%. In the presence of excess mAb the 125I-alpha BuTx bound could be precipitated by anti-IgG indicating that the mAb bound to only one of the two alpha BuTx binding sites on each AChR monomer. This site appeared to have a lower affinity for d-tubocurarine and decamethonium than the non-mAb site. Binding of five anti-site mAb was mutually competitive and four of them (AS2-AS5) were inhibited by other cholinergic ligands and influenced by four non-toxin binding site antibodies. One (AS1) bound within the toxin binding site yet outside the main neurotransmitter binding region. It is concluded that these five mAb distinguish between the two alpha BuTx binding sites on the Torpedo AChR, and bind only to the site which displays lower affinity for d-tubocurarine and other competitive ligands.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410274     DOI: 10.1111/j.1432-1033.1985.tb09054.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

Review 1.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 2.  Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.

Authors:  A Devillers-Thiéry; J L Galzi; J L Eiselé; S Bertrand; D Bertrand; J P Changeux
Journal:  J Membr Biol       Date:  1993-11       Impact factor: 1.843

3.  Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end-plates.

Authors:  J O Dolly; M Gwilt; G Lacey; J Newsom-Davis; A Vincent; P Whiting; D W Wray
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

4.  Immunochemical and pharmacological distinctions between curaremimetic neurotoxin binding sites of central, autonomic, and peripheral origin.

Authors:  R J Lukas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.

Authors:  G C Harcourt; N Sommer; J Rothbard; H N Willcox; J Newsom-Davis
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG).

Authors:  Y M Graus; P J van Breda Vriesman; M H de Baets
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

7.  Assembly of Torpedo acetylcholine receptors in Xenopus oocytes.

Authors:  M S Saedi; W G Conroy; J Lindstrom
Journal:  J Cell Biol       Date:  1991-03       Impact factor: 10.539

Review 8.  Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology.

Authors:  Miriam L Fichtner; Ruoyi Jiang; Aoibh Bourke; Richard J Nowak; Kevin C O'Connor
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.